Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protease inhibitor-induced lipodystrophy.

K Williamson1, A C Reboli, S M Manders

  • 1Department of Medicine, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School at Camden, USA.

Journal of the American Academy of Dermatology
|April 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Review of the Management of Obesity in Primary Care.

Clinical obesity·2025
Same author

Place-based household vouchers for locally supplied fruit and vegetables: the Fresh Street pilot cluster randomised controlled trial.

BMC public health·2025
Same author

Expectations of therapeutic radiography students in Wales about transitioning to practice during the Covid-19 pandemic as registrants on the HCPC temporary register.

Radiography (London, England : 1995)·2020
Same author

The radiology impact of healthcare errors during shift work.

Radiography (London, England : 1995)·2020
Same author

Microbial evaluation of automated sorting systems in stone fruit packinghouses during peach packing.

International journal of food microbiology·2018
Same author

Safety and efficacy of high-dose enteral, intravenous, and transdermal clonidine for the acute management of severe intractable childhood dystonia and status dystonicus: An illustrative case-series.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2017
Same journal

Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study.

Journal of the American Academy of Dermatology·2026
Same journal

Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
See all related articles

Protease inhibitor therapy for HIV infection can cause lipodystrophy, a condition characterized by abnormal fat distribution. This case highlights the importance of recognizing this side effect in patients with human immunodeficiency virus.

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cushing's disease classically presents with lipodystrophy, including central obesity, moon facies, and buffalo hump.
  • Protease inhibitors are a critical component of highly active antiretroviral therapy (HAART) for HIV infection.
  • Emerging evidence suggests a link between protease inhibitor use and the development of lipodystrophy syndromes.

Observation:

  • This report details a patient who developed lipodystrophy.
  • The patient was undergoing treatment with protease inhibitors for human immunodeficiency virus (HIV) infection.

Findings:

  • The observed lipodystrophy was directly attributed to the protease inhibitor therapy.
  • This represents a secondary form of lipodystrophy, distinct from endocrine causes like Cushing's disease.

Related Experiment Videos

Implications:

  • Clinicians should be vigilant for signs of lipodystrophy in HIV patients on protease inhibitor regimens.
  • Understanding this association is crucial for managing treatment-related adverse effects in HIV care.
  • Further research may explore mechanisms and alternative therapeutic strategies to mitigate this side effect.